141 related articles for article (PubMed ID: 12744075)
1. Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(1):45-50. PubMed ID: 12744075
[TBL] [Abstract][Full Text] [Related]
2. A new group of potential antituberculotics: hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2004; 49(3):265-8. PubMed ID: 15259766
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of piperidinylpropyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2003; 48(5):585-7. PubMed ID: 14976713
[TBL] [Abstract][Full Text] [Related]
4. QSAR study of antimycobacterial activity of quaternary ammonium salts of piperidinylethyl esters of alkoxysubstituted phenylcarbamic acids.
Waisser K; Dolezal R; Palát K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2006; 51(1):21-4. PubMed ID: 16821706
[TBL] [Abstract][Full Text] [Related]
5. [Antimycobacterial effects of pyrrolidinoethylester alkoxysubstituted phenylcarbamic acids].
Waisser K; Cizmárik J; Drazková K; Kaustová J
Ceska Slov Farm; 2002 May; 51(3):140-4. PubMed ID: 12058355
[TBL] [Abstract][Full Text] [Related]
6. [Derivatives of phenylcarbamic acid as potential antituberculotics].
Waisser K; Cizmárik J
Ceska Slov Farm; 2012 Feb; 61(1-2):17-20. PubMed ID: 22536648
[TBL] [Abstract][Full Text] [Related]
7. Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks?
Malík I; Csöllei J; Solovič I; Pospíšilová Š; Michnová H; Jampílek J; Čížek A; Kapustíková I; Čurillová J; Pecháčová M; Stolaříková J; Pecher D; Oravec M
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274224
[TBL] [Abstract][Full Text] [Related]
8. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
9. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
10. New S-benzylisothiosemicarbazones with antimycobacterial activity.
Petrlíková E; Waisser K; Heinisch L; Stolaříková J
Folia Microbiol (Praha); 2011 Jan; 56(1):10-2. PubMed ID: 21394476
[TBL] [Abstract][Full Text] [Related]
11. Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.
Dolezal M; Zitko J; Kesetovicová D; Kunes J; Svobodová M
Molecules; 2009 Oct; 14(10):4180-9. PubMed ID: 19924056
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
13. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
14. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
Krátký M; Vinšová J; Stolaříková J
Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activity of a series of pyrazinoic acid esters.
Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT
J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435
[TBL] [Abstract][Full Text] [Related]
18. 1-Aryl-5-benzylsulfanyltetrazoles, a new group of antimycobacterial compounds against potentially pathogenic strains.
Waisser K; Adamec J; Dolezal R; Kaustová J
Folia Microbiol (Praha); 2005; 50(3):195-7. PubMed ID: 16295656
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial activity of natural and semi-synthetic lignans.
Silva ML; Martins CH; Lucarini R; Sato DN; Pavanb FR; Freitas NH; Andrade LN; Pereira AC; Bianco TN; Vinholis AH; Cunha WR; Bastos JK; Silva R; Da Silva Filho AA
Z Naturforsch C J Biosci; 2009; 64(11-12):779-84. PubMed ID: 20158145
[TBL] [Abstract][Full Text] [Related]
20. N1-Hetaryl substituted pyridine- and pyrazinecarboxamidrazones with antimycobacterial activity.
Ranft D; Lehwark-Yvetot G; Schaper KJ; Büge A
Arch Pharm (Weinheim); 1997 Jun; 330(6):169-72. PubMed ID: 9297448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
